Related Experiment Video
Updated: Jul 25, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Potential for bleeding with the new beta-lactam antibiotics
Abstract:
Several new beta-lactam antibiotics impair normal hemostasis. Hypoprothrombinemia has occurred frequently with cephalosporins that possess a methylthiotetrazole substitution (cefamandole, moxalactam, and cefoperazone). The incidence ranges from 4% to 68%, and the risk is greatest in debilitated patients with cancer, intra-abdominal infection, or renal failure. Impaired platelet function caused by perturbation of agonist receptors on the platelet surface has occurred primarily with beta-lactam antibiotics having an alpha-carboxyl substitution (moxalactam, carbenicillin, and ticarcillin). These antibiotics often cause the template bleeding time to be markedly prolonged (greater than 20 minutes). Acylureidopenicillins, which lack the alpha-carboxyl marker, impair platelet function less frequently and only modestly prolong the bleeding time. If serious hemorrhage occurs, hypoprothrombinemia associated with methylthiotetrazole-substituted cephalosporins should be treated with fresh frozen plasma. Likewise, dangerous bleeding due to impaired platelet aggregation requires treatment with platelet concentrates.
Insights
Certain beta-lactam antibiotics can disrupt blood clotting. Cephalosporins with methylthiotetrazole may cause hypoprothrombinemia, while others with alpha-carboxyl groups can impair platelet function, increasing bleeding risk.
Area of Science:
- Pharmacology
- Hematology
- Internal Medicine
Background:
- Beta-lactam antibiotics are widely used, but some can interfere with hemostasis.
- Specific structural features of beta-lactams are associated with distinct hemostatic defects.
Purpose of the Study:
- To review the hemostatic complications associated with various beta-lactam antibiotics.
- To identify the specific antibiotic structures linked to hypoprothrombinemia and impaired platelet function.
Main Methods:
- Literature review of clinical studies and case reports on beta-lactam antibiotic-induced hemostatic abnormalities.
- Analysis of antibiotic structures and their correlation with observed bleeding risks.
Main Results:
- Cephalosporins with methylthiotetrazole substitution (e.g., cefamandole, moxalactam) frequently cause hypoprothrombinemia (4-68% incidence), especially in high-risk patients.
- Beta-lactams with alpha-carboxyl substitution (e.g., moxalactam, carbenicillin) impair platelet function, prolonging bleeding time.
- Acylureidopenicillins show less frequent and milder platelet dysfunction.
Conclusions:
- Hypoprothrombinemia from methylthiotetrazole-containing cephalosporins requires fresh frozen plasma for treatment.
- Platelet dysfunction necessitates platelet concentrate transfusions to manage serious hemorrhage.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance

